Loading...

MTD: Future Opportunities Will Be Unlocked By Pharmaceutical And Food Expansion

Published
08 Aug 24
Updated
01 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
3.0%
7D
3.3%

Author's Valuation

US$1.34k7.2% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 01 Nov 25

Fair value Increased 1.18%

Narrative Update on Mettler-Toledo International: Analyst Price Target Adjustment Analysts have raised their price target for Mettler-Toledo International, increasing the fair value estimate by $15.64 to $1,343.36. This adjustment reflects minor revisions in projected growth, margins, and market assumptions.

Shared on 18 Oct 25

Fair value Increased 1.46%

Pharmaceutical And Food Production Expansions Will Unlock Future Opportunities

Analysts have modestly raised their price target for Mettler-Toledo International by approximately $19 to $1,328. They cite incremental improvements in fair value and profit margin projections as the reason for this adjustment.

Shared on 04 Oct 25

Fair value Increased 1.09%

Pharmaceutical And Food Production Expansions Will Unlock Future Opportunities

Analysts have raised their price target for Mettler-Toledo International from $1,294.55 to $1,308.64, citing slightly improved revenue growth forecasts as well as modest adjustments in profitability and discount rates. What's in the News Between April 1, 2025 and June 30, 2025, Mettler-Toledo International repurchased 197,053 shares, representing 0.95 percent, for $218.74 million.

Shared on 27 Aug 25

Fair value Increased 1.42%

Pharmaceutical And Food Production Expansions Will Unlock Future Opportunities

The consensus Analyst Price Target for Mettler-Toledo International saw a marginal upward revision from $1,276 to $1,295, as key valuation metrics such as Future P/E and Discount Rate remained essentially unchanged. What's in the News Repurchased 197,053 shares (0.95%) for $218.74 million between April and June 2025; total buyback now 17,527,389 shares (64.7%) for $9,152.11 million under program initiated in 2010.

Shared on 07 May 25

Fair value Increased 0.89%

Pharmaceutical And Food Production Expansions Will Unlock Future Opportunities

Shared on 30 Apr 25

Fair value Increased 1.94%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Decreased 3.79%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 16 Apr 25

Fair value Decreased 1.53%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 0.64%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 0.45%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 0.22%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 10 Mar 25

Fair value Increased 4.88%

Supply Chain Optimization And Automation Investments Will Improve Efficiency

AnalystConsensusTarget has decreased revenue growth from 4.6% to 4.0%.